XML 42 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings per Share
 9 Months Ended
Nov. 01, 2014
Earnings Per Share [Abstract]  
Earnings per Share
5.            Earnings per Share

The following tables show the computation of basic and diluted earnings per share from continuing operations for each period presented (in thousands, except per share amounts):
 
Three Months Ended
 
Nine Months Ended
 
November 1, 2014
 
November 2, 2013
 
November 1, 2014
 
November 2, 2013
Basic EPS from continuing operations:
 
 
 
 
 
 
 
Loss from continuing operations
$
(5,107
)
 
$
(9,573
)
 
$
(5,961
)
 
$
(4,929
)
Less: Allocation of earnings to participating securities
—

 
—

 
—

 
—

Net loss from continuing operations allocated to common shares
(5,107
)
 
(9,573
)
 
(5,961
)
 
(4,929
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
31,794

 
31,854

 
31,681

 
32,307

Basic EPS from continuing operations
$
(0.16
)
 
$
(0.30
)
 
$
(0.19
)
 
$
(0.15
)
 
 
 
 
 
 
 
 
 
Three Months Ended
 
Nine Months Ended
 
November 1, 2014
 
November 2, 2013
 
November 1, 2014
 
November 2, 2013
Diluted EPS from continuing operations:
 

 
 

 
 
 
 
Loss from continuing operations
$
(5,107
)
 
$
(9,573
)
 
$
(5,961
)
 
$
(4,929
)
Less: Allocation of earnings to participating securities
—

 
—

 
—

 
—

Net loss from continuing operations allocated to common shares
(5,107
)
 
(9,573
)
 
(5,961
)
 
(4,929
)
 
 
 
 
 
 
 
 
Basic weighted average shares outstanding
31,794

 
31,854

 
31,681

 
32,307

Add: Dilutive effect of stock awards
—

 
—

 
—

 
—

Diluted weighted average shares outstanding
31,794

 
31,854

 
31,681

 
32,307

Diluted EPS from continuing operations
$
(0.16
)
 
$
(0.30
)
 
$
(0.19
)
 
$
(0.15
)

 
The number of shares attributable to stock options, SARs and non-vested stock grants that would have been considered dilutive securities, but were excluded from the calculation of diluted earnings per share because the effect was anti-dilutive were as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
November 1, 2014
 
November 2, 2013
 
November 1, 2014
 
November 2, 2013
Number of anti-dilutive shares due to net loss for the period
50

 
218

 
90

 
308

Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock
240


451


246


129